Back to Search Start Over

Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity

Authors :
Antonio Torsello
Laura Molteni
Elena Bresciani
Ramona Meanti
Silvia Coco
Laura Rizzi
Vittorio Locatelli
Robert J. Omeljaniuk
Meanti, R
Rizzi, L
Bresciani, E
Molteni, L
Locatelli, V
Coco, S
Omeljaniuk, R
Torsello, A
Source :
Pharmaceuticals, Volume 14, Issue 5, Pharmaceuticals, Vol 14, Iss 444, p 444 (2021)
Publication Year :
2021
Publisher :
MDPI, 2021.

Abstract

Hexarelin, a synthetic hexapeptide, exerts cyto-protective effects at the mitochondrial level in cardiac and skeletal muscles, both in vitro and in vivo, may also have important neuroprotective bioactivities. This study examined the inhibitory effects of hexarelin on hydrogen peroxide (H2O2)-induced apoptosis in Neuro-2A cells. Neuro-2A cells were treated for 24 h with various concentrations of H2O2 or with the combination of H2O2 and hexarelin following which cell viability and nitrite (NO2−) release were measured. Cell morphology was also documented throughout and changes arising were quantified using Image J skeleton and fractal analysis procedures. Apoptotic responses were evaluated by Real-Time PCR (caspase-3, caspase-7, Bax, and Bcl-2 mRNA levels) and Western Blot (cleaved caspase-3, cleaved caspase-7, MAPK, and Akt). Our results indicate that hexarelin effectively antagonized H2O2-induced damage to Neuro-2A cells thereby (i) improving cell viability, (ii) reducing NO2− release and (iii) restoring normal morphologies. Hexarelin treatment also reduced mRNA levels of caspase-3 and its activation, and modulated mRNA levels of the BCL-2 family. Moreover, hexarelin inhibited MAPKs phosphorylation and increased p-Akt protein expression. In conclusion, our results demonstrate neuroprotective and anti-apoptotic effects of hexarelin, suggesting that new analogues could be developed for their neuroprotective effects.

Details

Language :
English
Database :
OpenAIRE
Journal :
Pharmaceuticals, Volume 14, Issue 5, Pharmaceuticals, Vol 14, Iss 444, p 444 (2021)
Accession number :
edsair.doi.dedup.....ba9311c639c37d5adf06c6eaf8e47914